Silence Therapeutics PLC Sponsored ADR (SLN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

Today is shaping up negative for Silence Therapeutics plc ( NASDAQ:SLN ) shareholders, with the analysts delivering a... LONDON, March 05, 2025--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or ...

HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note ...

Silence Therapeutics (NASDAQ:SLN – Get Free Report) is expected to be announcing its earnings results before the market opens ...

U.S. stocks rallied to their best day in months on Friday as Wall Street’s roller coaster suddenly shot back upward. That still wasn’t enough to keep the U.S. market from a fourth straight losing week ...

SLN (“Silence” or the “Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) the ...

SLN has started construction and mobilization for a 10,000 square foot expanded terminal. Salina Airport Authority Executive ...

Good morning and good afternoon, everyone. Thank you for joining us today. My name is Gem Hopkins, Vice President of Investor Relations and Corporate Communications at Silence. Joining me on today ...